Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Thoracic 1Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Ovarian Neoplasms 6Carcinoma, Ovarian Epithelial 4Urinary Bladder Neoplasms 2Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Recurrence 1Prostatic Neoplasms 1Lung Neoplasms 1Dysgerminoma 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Paclitaxel 8Filgrastim 8Carboplatin 8Peripheral Blood Stem Cell Transplantation 6Ifosfamide 6Etoposide 4Temozolomide 3pembrolizumab 2pegfilgrastim 2ixabepilone 2etoposide phosphate 2Thiotepa 2Melphalan 2Gemcitabine 2Cisplatin 2Amifostine 2sodium thiosulfate 1regorafenib 1carboxyamido-triazole 1aflibercept 1Trabectedin 1Topotecan 1Taxes 1Surveys and Questionnaires 1Restraint, Physical 1Radiotherapy 1Quality of Life 1Psychiatric Rehabilitation 1Patient Reported Outcome Measures 1PT-100 dipeptide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × Lapatinib × Gynecologic × Clear all
NCT00313599 2014-07-02

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

University of California, San Francisco

Phase 1 Completed
28 enrolled
BreastCNSGastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Dysgerminoma, Esophageal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡